Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
HRs and ORs for the 10-year signature genes in TransATAC and POLAR ...
Flowchart of gene signature derivation in the microarray and TransATAC ...
Representative examples of DCIS from the Duke and TransATAC cohorts ...
Covariate Distributions in NSABP B-14 and TransATAC Meta-Analysis ...
(PDF) Predictive algorithms for adjuvant therapy: TransATAC
Takeaways From TransATAC Trial on Comparing Prognostic Signatures
Statistical analysis for all and distant recurrences in the TransATAC ...
Demographics of TransATAC and POLAR cohorts | Download Table
Statistical analysis of TransATAC validation cohort | Download Table
AccuStem’s StemPrintER Demonstrates Prognostic Utility in TransATAC ...
CONSORT diagram for the availability of samples for analysis from the ...
多基因检测到底差别在哪？TransATAC研究从分子特征找答案_评分
Distant Recurrence Risk Prediction – Eurobio Scientific
(PDF) Molecular Drivers of Onco type DX, Prosigna, EndoPredict, and the ...
Technology - AccuStem
Molecular Biomarkers for Breast Cancer Prognosis - Clinical Tree
Validation of the OncoMasTR Risk Score in Estrogen Receptor–Positive ...
多基因检测到底差别在哪？TransATAC研究从分子特征找答案 - 高龄备孕网
Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast ...
(PDF) Effects of cyclin D1 gene amplification and protein expression on ...
(PDF) 2OPrognostic value of endopredict for invasive lobular carcinomas ...
Comparison of the Demographics Between the HR Group of ATAC and the ...
Time to recurrence for HER-2positive and HER-2-negative subgroups in ...
多基因检测到底差别在哪？TransATAC研究从分子特征找答案_腾讯新闻
多基因检测到底差别在哪？TransATAC研究从分子特征找答案医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Accurately predict breast cancer recurrence | Eurobio Oncology
בדיקה גנומית לסרטן השד - Oncotype DX®️ Breast Recurrence Score
(PDF) Validation of the OncoMASTR risk score in estrogen receptor ...
Prediction of late distant recurrence in patients with oestrogen ...
AccuStem’s StemPrintER Demonstrates Prognostic Utility in
Supplementary Table S1 from Validation of the OncoMasTR Risk Score in ...
(PDF) Abstract S6-05: Comprehensive comparison of prognostic signatures ...
Comparing Diagnostic Tests – Eurobio Scientific
The Oncotype DX® Assay in the Contemporary Management of Invasive Early ...
Effects of cyclin D1 gene amplification and protein expression on time ...
Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence ...
Supplementary Table S2 from Validation of the OncoMasTR Risk Score in ...
(PDF) Immunohistochemical BAG1 expression improves the estimation of ...
Prediction of late distant recurrence in estrogen receptor positive ...
Time to recurrence hazard ratios for anastrozole versus tamoxifen by ...
早期乳腺癌多基因检测：精准征途，共达未来 – 数问观止医学检验中心
乳腺癌21基因检测在国内/外哪家公司做比较好？费用大概是多少？ - 知乎
Press Release Archives - AccuStem
Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor ...
[보고서]맞춤의료를 위한 체외진단다지표검사(IVDMIA)의료기기 평가기술 개발 연구
Individual clinical and immunohistochemical markers for the prediction ...
Prédire avec précision la récidive du cancer du sein | Eurobio Oncology
【与乳同行，基因课堂】EndoPredict®（EPclin，12基因，问谱特®）天津站 ——早期乳腺癌多基因检测与淋巴结阳性患者精准诊疗 ...
Why Prosigna - Prosigna
Table 5 Assay
Cursos de Instrucción de Pilotos | Wiki Achs | Fandom
Prosigna
(PDF) Prediction of Risk of Distant Recurrence Using the 21-Gene ...
Baseline Characteristics According to Trial | Download Table
Slide 19
7364738 atac-100 | PDF
Prosigna - Resident Laboratory
LOGO
39 Year-Old | Case Studies | Oncotype DX Breast Recurrence Score
Recommendations from the EGAPP Working Group: does the use of Oncotype ...
(PDF) Prediction of late distant recurrence in patients with oestrogen ...
PERCHÉ PROSIGNA - Prosigna
Slide 15
Utility of the 21-Gene Recurrence Score in Node-Positive Breast Cancer
POR QUÉ PROSIGNA - Prosigna
Prediction of Late Distant Recurrence After 5 Years of Endocrine ...
Predicted risk of recurrence over time based on cytoplasmic intensity ...
Role of biologic therapy and chemotherapy in hormone receptor- and HER2 ...
Performance of the Breast Cancer Index versus Onco type DX Recurrence ...
Individualizing Adjuvant Therapy in Women With Hormone Receptor ...
Figure 1 from The OncoMasTR Test Predicts Distant Recurrence in ...
Fig. 2 (a) Oncotype DX-based risk stratification. (b) MammaPrint-based ...
Interpret Results for the Oncotype DX Breast Recurrence Score® test ...
Predicting breast cancer recurrence - Eureka | Patsnap
Interpreting the Results | Oncotype DX® Test | Oncotype IQ® Canada
Distant Recurrence Risk Prediction | Eurobio-Scientific
70387-5/asset/d722695e-7bd9-43fd-873e-40f3d4733735/main.assets/gr1_lrg.jpg)
70387-5/asset/31b7e77b-e8d0-4dd3-9ac0-aed869842a1d/main.assets/gr2_lrg.jpg)
70387-5/asset/61fde5f5-7801-4f08-bdce-3f0c18fb636c/main.assets/gr3_lrg.jpg)
